Objective The SmartScreen Consortium will transfer cutting edge Nuclear Magnetic Resonance technology for drug screening and drug design from the Host (UNIFRANMR) to three Industrial Partners, a large pharmaceutical company and a start-up company. The core technologies used by the Consortium will be protein based Nuclear Magnetic Resonance (NMR) screening using isotopically labelled proteins and various ligand based NMR screening techniques. As a vital prerequisite for the screening the Consortium will establish protocols to produce large amounts of uniformly or partially labelled proteins.The Consortium will also include a start-up company focussing on chemical synthetic strategies to access molecules with modified or enhanced properties for NMR based screening. The Consortium will have the goal to form lasting partnerships between its members by exchanging research staff between the laboratory of UNIFRANMR and the laboratories of the Industrial Partners. The training will include special lectures, workshops and seminars. The researchers will receive hands-on training by doing the research under the guidance of highly qualified scientific staff.The project will enable the Industrial Partners to expand their research programs, to use NMR screening technology to develop new drugs and to synthesize inhibitors with optimised properties for NMR based screening. The host will mutually benefit from the training effort by extending its capacity in applied scientific subsection of Nuclear Magnetic Resonance Spectroscopy. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverymedical and health sciencesbasic medicinemedicinal chemistrynatural sciencesearth and related environmental sciencesgeologymineralogycrystallographynatural scienceschemical sciencesanalytical chemistrymass spectrometrynatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes Keywords Biochemistry Drug Design Programme(s) FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006 Topic(s) MOBILITY-1.3.2 - Marie Curie Host Fellowships - Transfer of knowledge (TOK) - Industry-Academia Strategic Partnership Scheme Call for proposal FP6-2004-MOBILITY-3 See other projects for this call Funding Scheme TOK - Marie Curie actions-Transfer of Knowledge Coordinator JOHANN WOLFGANG GOETHE-UNIVERSITAT Address Senckenberganlage 31 Frankfurt/main Germany See on map Links Website Opens in new window EU contribution € 0,00 Participants (3) Sort alphabetically Sort by EU Contribution Expand all Collapse all PHOSPHOENIX SARL France EU contribution € 0,00 Address 115, rue de l'abbã© groult Paris See on map Links Website Opens in new window PROTERA S.R.L. Italy EU contribution € 0,00 Address Viale delle idee 26 Sesto f.no firenze See on map Links Website Opens in new window SOLVAY PHARMACEUTICALS B.V. Netherlands EU contribution € 0,00 Address C.j. van houtenlaan 36 Weesp See on map Links Website Opens in new window
